Ligand Pharmaceuticals Inc (NASDAQ:LGND)

161.77
Delayed Data
As of Apr 24
 -5.45 / -3.26%
Today’s Change
104.25
Today|||52-Week Range
184.79
+18.14%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$3.7B

Company Description

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.

Contact Information

Ligand Pharmaceuticals, Inc.
3911 Sorrento Valley Boulevard
San Diego California 92121
P:(858) 550-7500
Investor Relations:

Employees

Shareholders

Mutual fund holders65.63%
Other institutional53.21%
Individual stakeholders18.71%

Top Executives

John L. HigginsChief Executive Officer & Director
Matthew W. FoehrPresident & Chief Operating Officer
Matthew E. KorenbergCFO, Principal Accounting Officer & VP-Finance
Vincent AntleVP-Technical Operations & Quality Assurance
Charles S. BerkmanSecretary, Vice President & General Counsel